Cargando…

N-Acetylaspartate Reduction in the Medial Prefrontal Cortex Following 8 weeks of Risperidone Treatment in First-Episode Drug-Naïve Schizophrenia Patients

It is unclear whether N-acetylaspartate (NAA) depletions documented in schizophrenia patients might be due to the disease progression or medications. Here we investigated longitudinal NAA changes in drug-naïve first-episode patients (FEP) who are relatively free from chronicity. Forty-two drug-naïve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zong, Xiaofen, Hu, Maolin, Li, Zongchang, Cao, Hongbao, He, Ying, Liao, Yanhui, Zhou, Jun, Sang, Deen, Zhao, Hongzeng, Tang, Jinsong, Lv, Luxian, Chen, Xiaogang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894446/ https://www.ncbi.nlm.nih.gov/pubmed/25778460 http://dx.doi.org/10.1038/srep09109

Ejemplares similares

Association of telomere length and mitochondrial DNA copy number with risperidone treatment response in first-episode antipsychotic-naïve schizophrenia
por: Li, Zongchang, et al.
Publicado: (2015)

Epigenetic clock analysis of blood samples in drug-naive first-episode schizophrenia patients
por: Li, Zongchang, et al.
Publicado: (2023)

Striatum-related spontaneous coactivation patterns predict treatment response on positive symptoms of drug-naive first-episode schizophrenia with risperidone monotherapy
por: Zong, Xiaofen, et al.
Publicado: (2023)

DNA Methylation Basis in the Effect of White Matter Integrity Deficits on Cognitive Impairments and Psychopathological Symptoms in Drug-Naive First-Episode Schizophrenia
por: Zong, Xiaofen, et al.
Publicado: (2021)

COMT, 5-HTR2A, and SLC6A4 mRNA Expressions in First-Episode Antipsychotic-Naïve Schizophrenia and Association With Treatment Outcomes
por: Li, Zongchang, et al.
Publicado: (2018)

Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients
por: Birur, Badari, et al.
Publicado: (2020)

Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis
por: Noto, Cristiano, et al.
Publicado: (2015)

Longitudinal multi-omics alterations response to 8-week risperidone monotherapy: Evidence linking cortical thickness, transcriptomics and epigenetics
por: Zong, Xiaofen, et al.
Publicado: (2023)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Grošić, Vladimir, et al.
Publicado: (2014)

Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia
por: Song, Xueqin, et al.
Publicado: (2014)

Reduction of N-acetylaspartate in the medial prefrontal cortex correlated with symptom severity in obsessive-compulsive disorder: meta-analyses of (1)H-MRS studies
por: Aoki, Yuta, et al.
Publicado: (2012)

Antioxidant Enzymes and Weight Gain in Drug-naive First-episode Schizophrenia Patients Treated with Risperidone for 12 Weeks: A Prospective Longitudinal Study
por: Liu, Haixia, et al.
Publicado: (2022)

Anterior Cingulate Cortex Glutamate Levels Are Related to Response to Initial Antipsychotic Treatment in Drug-Naive First-Episode Schizophrenia Patients
por: Li, Jinguang, et al.
Publicado: (2020)

Comparative study of clozapine versus risperidone in treatment-naive, first-episode schizophrenia: A pilot study
por: Sahni, Sukhtej, et al.
Publicado: (2016)

Metabolite differences in the medial prefrontal cortex in schizophrenia patients with and without persistent auditory verbal hallucinations: a (1)H MRS study
por: Wang, Qianjin, et al.
Publicado: (2022)

Higher glutamatergic activity in the medial prefrontal cortex in chronic ketamine users
por: Wu, Qiuxia, et al.
Publicado: (2022)

N-Acetylaspartate Is an Important Brain Osmolyte
por: Warepam, Marina, et al.
Publicado: (2020)

Decreased Functional Connectivity of Insular Cortex in Drug Naïve First Episode Schizophrenia: In Relation to Symptom Severity
por: Pang, Lijuan, et al.
Publicado: (2017)

Short-term Effects of Risperidone Monotherapy on Spontaneous Brain Activity in First-episode Treatment-naïve Schizophrenia Patients: A Longitudinal fMRI Study
por: Hu, Mao-Lin, et al.
Publicado: (2016)

Gut microbial biomarkers for the treatment response in first-episode, drug-naïve schizophrenia: a 24-week follow-up study
por: Yuan, Xiuxia, et al.
Publicado: (2021)

Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial
por: Zhao, Jingyuan, et al.
Publicado: (2015)

Abnormal Brain Network Interaction Associated With Positive Symptoms in Drug-Naive Patients With First-Episode Schizophrenia
por: Yuan, Liu, et al.
Publicado: (2022)

The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study
por: Liu, Jiahong, et al.
Publicado: (2021)

Studies on the Role of N-Acetylaspartic Acid in Mammalian Brain
por: Jacobson, K. Bruce
Publicado: (1959)

Extracellular N-Acetylaspartate in Human Traumatic Brain Injury
por: Shannon, Richard J., et al.
Publicado: (2016)

Reversible Dysphagia Associated With Risperidone Presenting With a Choking Episode
por: Pandit, Shradha, et al.
Publicado: (2023)

Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
por: Lang, Xiaoe, et al.
Publicado: (2023)

The month of walking alone and BDNF level differ between drug-naive first-episode schizophrenia patients and healthy controls
por: Zhang, Zhenmei, et al.
Publicado: (2023)

Abnormal functional connectivity of the striatum in first‐episode drug‐naive early‐onset Schizophrenia
por: Zhang, Yan, et al.
Publicado: (2022)

Disrupted Structural and Functional Connectivity in Prefrontal-Hippocampus Circuitry in First-Episode Medication-Naïve Adolescent Depression
por: Geng, Haiyang, et al.
Publicado: (2016)

Metabolites Alterations in the Medial Prefrontal Cortex of Methamphetamine Users in Abstinence: A (1)H MRS Study
por: Wu, Qiuxia, et al.
Publicado: (2018)

Education mitigates age-related decline in N-Acetylaspartate levels
por: Erickson, Kirk I, et al.
Publicado: (2015)

Poststroke Emotionalism with Dacrystic (Crying) Episodes – Making a Case for Risperidone
por: Imarhiagbe, Frank Aiwansoba, et al.
Publicado: (2018)

Relationship between TNF-α levels and psychiatric symptoms in first-episode drug-naïve patients with schizophrenia before and after risperidone treatment and in chronic patients
por: Lin, Chen, et al.
Publicado: (2021)

Effect Of Risperidone And Olanzapine On The Metabolic Profile Of Drug Naïve Bipolar Disorder Patients.
por: Gupta, Gajal, et al.
Publicado: (2022)

Metabolic biomarkers of risperidone-induced weight gain in drug-naïve patients with schizophrenia
por: Qiu, Yuying, et al.
Publicado: (2023)

Association between Changes in Total Antioxidant Levels and Clinical Symptom Improvement in Patients with Antipsychotic-Naïve First-Episode Schizophrenia after 3 Months of Risperidone Monotherapy
por: Wang, Keqiang, et al.
Publicado: (2022)

Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis
por: Vázquez-Bourgon, Javier, et al.
Publicado: (2022)

Lateralized Contributions of Medial Prefrontal Cortex Network to Episodic Memory Deficits in Subjects With Amnestic Mild Cognitive Impairment
por: Ye, Qing, et al.
Publicado: (2021)

Electrical stimulation mapping in the medial prefrontal cortex induced auditory hallucinations of episodic memory: A case report
por: Long, Qiting, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_64rjph50oa5qbbq3jdbogjcprv